vs
Side-by-side financial comparison of FIRSTSUN CAPITAL BANCORP (FSUN) and Vital Farms, Inc. (VITL). Click either name above to swap in a different company.
Vital Farms, Inc. is the larger business by last-quarter revenue ($213.6M vs $110.0M, roughly 1.9× FIRSTSUN CAPITAL BANCORP). FIRSTSUN CAPITAL BANCORP runs the higher net margin — 19.6% vs 7.6%, a 12.0% gap on every dollar of revenue. Over the past eight quarters, Vital Farms, Inc.'s revenue compounded faster (20.2% CAGR vs 6.9%).
FirstSun Capital Bancorp is a U.S.-headquartered financial holding company that offers a comprehensive range of banking and financial services, including commercial and consumer lending, deposit products, wealth management, and treasury solutions. It mainly serves individual customers, small and medium-sized enterprises, and corporate clients across U.S. regional markets.
Vital Tomosi Dairy Limited is a dairy processing company in Uganda. The company is a joint venture between Vital Capital Fund, "an impact investing fund primarily focused on Sub-Saharan Africa", and "Tomosi Dairy Farms, a Ugandan producer of dairy products".
FSUN vs VITL — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $110.0M | $213.6M |
| Net Profit | $21.6M | $16.3M |
| Gross Margin | — | 35.8% |
| Operating Margin | — | 10.0% |
| Net Margin | 19.6% | 7.6% |
| Revenue YoY | — | 28.7% |
| Net Profit YoY | -8.4% | 54.3% |
| EPS (diluted) | $0.76 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $110.0M | — | ||
| Q4 25 | $110.2M | $213.6M | ||
| Q3 25 | $107.3M | $198.9M | ||
| Q2 25 | $105.6M | $184.8M | ||
| Q1 25 | $96.2M | $162.2M | ||
| Q4 24 | $98.7M | $166.0M | ||
| Q3 24 | $98.2M | $145.0M | ||
| Q2 24 | $96.2M | $147.4M |
| Q1 26 | $21.6M | — | ||
| Q4 25 | $24.8M | $16.3M | ||
| Q3 25 | $23.2M | $16.4M | ||
| Q2 25 | $26.4M | $16.6M | ||
| Q1 25 | $23.6M | $16.9M | ||
| Q4 24 | $16.4M | $10.6M | ||
| Q3 24 | $22.4M | $7.4M | ||
| Q2 24 | $24.6M | $16.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 35.8% | ||
| Q3 25 | — | 37.7% | ||
| Q2 25 | — | 38.9% | ||
| Q1 25 | — | 38.5% | ||
| Q4 24 | — | 36.1% | ||
| Q3 24 | — | 36.9% | ||
| Q2 24 | — | 39.1% |
| Q1 26 | — | — | ||
| Q4 25 | 29.0% | 10.0% | ||
| Q3 25 | 26.4% | 10.8% | ||
| Q2 25 | 31.2% | 12.9% | ||
| Q1 25 | 30.9% | 13.4% | ||
| Q4 24 | 20.4% | 7.8% | ||
| Q3 24 | 29.1% | 6.4% | ||
| Q2 24 | 32.3% | 11.6% |
| Q1 26 | 19.6% | — | ||
| Q4 25 | 22.5% | 7.6% | ||
| Q3 25 | 21.6% | 8.3% | ||
| Q2 25 | 25.0% | 9.0% | ||
| Q1 25 | 24.5% | 10.4% | ||
| Q4 24 | 16.6% | 6.4% | ||
| Q3 24 | 22.8% | 5.1% | ||
| Q2 24 | 25.5% | 11.1% |
| Q1 26 | $0.76 | — | ||
| Q4 25 | $0.89 | $0.35 | ||
| Q3 25 | $0.82 | $0.36 | ||
| Q2 25 | $0.93 | $0.36 | ||
| Q1 25 | $0.83 | $0.37 | ||
| Q4 24 | $0.57 | $0.23 | ||
| Q3 24 | $0.79 | $0.16 | ||
| Q2 24 | $0.88 | $0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $413.7M | $48.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.2B | $351.3M |
| Total Assets | $8.6B | $518.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $413.7M | — | ||
| Q4 25 | $652.6M | $48.8M | ||
| Q3 25 | $659.9M | $93.8M | ||
| Q2 25 | $785.1M | $108.2M | ||
| Q1 25 | $621.4M | $156.3M | ||
| Q4 24 | $615.9M | $150.6M | ||
| Q3 24 | $573.7M | $149.5M | ||
| Q2 24 | $535.8M | $133.2M |
| Q1 26 | $1.2B | — | ||
| Q4 25 | $1.2B | $351.3M | ||
| Q3 25 | $1.1B | $331.2M | ||
| Q2 25 | $1.1B | $309.8M | ||
| Q1 25 | $1.1B | $288.9M | ||
| Q4 24 | $1.0B | $269.3M | ||
| Q3 24 | $1.0B | $253.4M | ||
| Q2 24 | $996.6M | $238.4M |
| Q1 26 | $8.6B | — | ||
| Q4 25 | $8.5B | $518.7M | ||
| Q3 25 | $8.5B | $481.5M | ||
| Q2 25 | $8.4B | $430.8M | ||
| Q1 25 | $8.2B | $376.9M | ||
| Q4 24 | $8.1B | $359.3M | ||
| Q3 24 | $8.1B | $344.7M | ||
| Q2 24 | $8.0B | $320.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $5.8M |
| Free Cash FlowOCF − Capex | — | $-32.1M |
| FCF MarginFCF / Revenue | — | -15.1% |
| Capex IntensityCapex / Revenue | — | 17.8% |
| Cash ConversionOCF / Net Profit | — | 0.35× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-48.2M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $111.5M | $5.8M | ||
| Q3 25 | $49.4M | $23.4M | ||
| Q2 25 | $15.0M | $-761.0K | ||
| Q1 25 | $26.4M | $5.3M | ||
| Q4 24 | $101.1M | $14.8M | ||
| Q3 24 | $48.1M | $10.0M | ||
| Q2 24 | $20.9M | $16.1M |
| Q1 26 | — | — | ||
| Q4 25 | $104.0M | $-32.1M | ||
| Q3 25 | $47.6M | $-10.6M | ||
| Q2 25 | $13.0M | $-7.6M | ||
| Q1 25 | $24.3M | $2.1M | ||
| Q4 24 | $95.7M | $-3.4M | ||
| Q3 24 | $47.1M | $6.4M | ||
| Q2 24 | $19.9M | $10.5M |
| Q1 26 | — | — | ||
| Q4 25 | 94.3% | -15.1% | ||
| Q3 25 | 44.4% | -5.3% | ||
| Q2 25 | 12.3% | -4.1% | ||
| Q1 25 | 25.3% | 1.3% | ||
| Q4 24 | 97.0% | -2.0% | ||
| Q3 24 | 47.9% | 4.4% | ||
| Q2 24 | 20.6% | 7.2% |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 17.8% | ||
| Q3 25 | 1.6% | 17.1% | ||
| Q2 25 | 1.9% | 3.7% | ||
| Q1 25 | 2.1% | 1.9% | ||
| Q4 24 | 5.5% | 10.9% | ||
| Q3 24 | 1.1% | 2.5% | ||
| Q2 24 | 1.1% | 3.8% |
| Q1 26 | — | — | ||
| Q4 25 | 4.49× | 0.35× | ||
| Q3 25 | 2.13× | 1.43× | ||
| Q2 25 | 0.57× | -0.05× | ||
| Q1 25 | 1.12× | 0.31× | ||
| Q4 24 | 6.18× | 1.40× | ||
| Q3 24 | 2.15× | 1.34× | ||
| Q2 24 | 0.85× | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FSUN
| Net Interest Income | $82.8M | 75% |
| Noninterest Income | $27.2M | 25% |
VITL
| Eggs And Egg Related Products | $205.8M | 96% |
| Butter And Butter Related Products | $7.7M | 4% |
